Back to results
US 5,776,494 AGranted
Pharmaceuticals compositions containing gellants in the form of alkyl amides of di-and tri-carboxylic acids
AssigneeThe Procter & Gamble Company
InventorsGerald John Guskey, Raymond Joseph Lo, David Frederick Swaile
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical compositions useful as carriers for topical skin actives such as moisturizers, protectants, antiperspirants, deodorants and the like; and more particularly, to such pharmaceutical compositions in the form of a gel or gel stick.
Claims20
A pharmaceutical composition comprising:
- A.) a safe and effective amount of at least one pharmaceutical active;
- B.) a gellant of the formula:
- ##STR8## a) R.sub.1 is nil, hydroxy, hydrogen, aryl, siloxane or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C.sub.1 -C.sub.22 alkyl, C.sub.1 -C.sub.22 alkenyl, C.sub.1 -C.sub.22 alkoxy, C.sub.1 -C.sub.22 alkyl esters, C.sub.1 -C.sub.22 alkyl ethers, or C.sub.1 -C.sub.22 alkyl substituted aryl;
- b) R.sub.2, R.sub.4, R.sub.5 and R.sub.6 are independently or together, hydrogen, hydroxy, aryl, siloxane or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C.sub.1 -C.sub.22 alkyl, C.sub.1 -C.sub.22 alkenyl, C.sub.1 -C.sub.22 alkoxy, C.sub.1 -C.sub.22 alkyl esters, C.sub.1 -C.sub.22 alkyl ethers, or C.sub.1 -C.sub.22 alkyl substituted aryl;
- c) R.sub.3 is nil, hydroxy, hydrogen, saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkenyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkyl esters or C.sub.1 -C.sub.4 alkyl ethers;
- d) R.sub.7 and R.sub.8 are independently or together, nil, hydrogen, hydroxy, aryl, siloxane or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C.sub.1 -C.sub.22 alkyl, C.sub.1 -C.sub.22 alkenyl, C.sub.1 -C.sub.22 alkoxy, C.sub.1 -C.sub.22 alkyl esters, C.sub.1 -C.sub.22 alkyl ethers, or C.sub.1 -C.sub.22 alkyl substituted aryl;
- e) R.sub.9 is nil or hydrogen;
- f) R.sub.10 and R.sub.11 are independently or together, nil, hydrogen, hydroxy, aryl, siloxane or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkenyl, C.sub.1 -C.sub.6 alkoxy, C.sub.1 -C.sub.6 alkyl esters, C.sub.1 -C.sub.6 alkyl ethers, or C.sub.1 -C.sub.6 alkyl substituted aryl;
- g) X is nil, nitrogen, aryl or .paren open-st.CH.sub.2 .paren close-st..sub.n where n is an integer from 1 to 6;
- h) Y is nil, acyl or carbonyl;
- i) Z is nil, hydrogen, hydroxy, aryl, siloxane, nitrogen or saturated or unsaturated, substituted or unsubstituted, straight, branched or cyclic chain C.sub.1 -C.sub.22 alkyl, C.sub.1 -C.sub.22 alkenyl, C.sub.1 -C.sub.22 alkoxy, C.sub.1 -C.sub.22 alkyl esters, C.sub.1 -C.sub.22 alkyl ethers, or C.sub.1 -C.sub.22 alkyl substituted aryl;
- and
- j) "a" is a double or single bond provided:
- (i) when X is nil, Y, Z, R.sub.3, R.sub.7 and R.sub.8 are nil, C' is bonded directly to C" and R.sub.1 is not a hydrogen;
- (ii) when X and Z are not nil and Y is nil, X is directly bonded to Z;
- (iii) when Z is nil, a hydrogen or a hydroxy, R.sub.7 and R.sub.8 are nil;
- and
- (iv) when "a" is a double bond, R.sub.3 and R.sub.9 are nil;
- and
- C.) an anhydrous liquid carrier.
17 more elements
A pharmaceutical composition, comprising:
- a.) a safe and effective amount of at least one pharmaceutical active;
- b.) a non-triglyceride gelling agent compound, comprising:
- i.) a C.sub.2 -C.sub.12 linear backbone having terminal hydrogen bonding functional groups, each hydrogen bonding functional group carrying thereon a non-polymeric, organic side chain;
- and
- ii.) an additional non-polymeric, organic side chain attached to the backbone by an acyl-amide functional group such that the acyl portion of the acylamide functional group attaches to the backbone wherein the side chains of the hydrogen bonding functional groups are disposed on the same axial side of the backbone such the additional side chain is disposed on a planar side opposite the side chains of the hydrogen bonding functional groups;
- and
- c.) an anhydrous liquid carrier.
4 more elements
Dependencies are inferred from the claim text.